Saab AB (SAABF) Financials Oct 21, 2014, 7:10 p.m.
Income
Saab AB (SAABF) Financials Oct 21, 2014, 7:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Saab AB
Fiscal year is January-December. All values SEK millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 24.65B 24.43B 23.5B 24.01B 23.75B
Cost of Goods Sold (COGS) incl. D&A 19.18B 18.98B 17.38B 17.39B 17.42B
COGS excluding D&A 17.8B 17.68B 16.14B 16.22B 16.38B
Depreciation & Amortization Expense 1.38B 1.3B 1.24B 1.17B 1.05B
Depreciation 519M 490M 466M 439M -
Amortization of Intangibles 858M 805M 774M 733M -
Gross Income 5.47B 5.46B 6.12B 6.62B 6.33B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.1B 4.14B 4.44B 4.89B 4.96B
Research & Development 1.13B 1.18B 1.34B 1.51B 1.76B
Other SG&A 2.97B 2.96B 3.1B 3.39B 3.19B
Other Operating Expense 115M 41M 59M 13M 26M
Unusual Expense 73M 557M 57M (190M) 231M
EBIT after Unusual Expense (73M) (557M) (57M) 190M (231M)
Non Operating Income/Expense (92M) 56M 1.18B (48M) 204M
Non-Operating Interest Income 80M 61M 186M 168M 62M
Equity in Affiliates (Pretax) - - - 0 -
Interest Expense 148M 104M 140M 44M 428M
Gross Interest Expense 148M 104M 140M 44M 428M
Interest Capitalized 0 0 0 0 0
Pretax Income 1.02B 736M 2.8B 1.98B 954M
Income Tax 277M 322M 566M 443M 237M
Income Tax - Current Domestic 183M 348M 424M 571M -
Income Tax - Current Foreign - 0 - 0 -
Income Tax - Deferred Domestic 94M (26M) 142M (128M) -
Income Tax - Deferred Foreign - 0 - 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates (41M) 40M (12M) 27M 25M
Other After Tax Income (Expense) - 0 0 - 0
Consolidated Net Income 699M 454M 2.22B 1.56B 742M
Minority Interest Expense 13M 21M (8M) (25M) 1M
Net Income 686M 433M 2.23B 1.59B 741M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 - -
Cumulative Effect - Accounting Chg 0 0 0 - -
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 686M 433M 2.23B 1.59B 741M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 686M 433M 2.23B 1.59B 741M
EPS (Basic) 6.45 4.12 21.19 15.00 6.98
Basic Shares Outstanding 106.34M 105.22M 104.98M 105.63M 106.13M
EPS (Diluted) 6.28 3.97 20.38 14.52 6.79
Diluted Shares Outstanding 109.15M 109.15M 109.15M 109.15M 109.15M
EBITDA 2.63B 2.58B 2.86B 2.88B 2.39B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...
Continue Reading
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Top 5 Most Recently Viewed Articles
U.S. GoldMining Champions Alaska's Development Efforts U.S. GoldMining Inc. (NASDAQ: USGO) expresses strong support for Alaska's recent push to enhance its critical road infrastructure. This initiative, led by the Alaska Industrial Development and Export Authority (AIDEA), is set to significantly improve access to the Whistler Gold-Copper Project. The proposed West...
Continue Reading
New StorageMart Facility Unveiled in Brighton StorageMart, a distinguished name in the self-storage industry, has recently opened a new facility on Wellington Road in Brighton. This latest development marks an exciting chapter of revitalization, successfully blending the site's historic charm with contemporary storage solutions that the community can rely on. A Tribute to...
Continue Reading
374Water Welcomes New Investor Relations Leader 374Water Inc. has made a significant strategic move by appointing Jim Siccardi as the Senior Vice President of Investor Relations. With an impressive background in enhancing shareholder value and building robust investor relations strategies, Siccardi is expected to boost the company's communication strategies within capital...
Continue Reading
BOC Aviation Expands Fleet with 50 Boeing 737-8 Aircraft BOC Aviation has recently enhanced its fleet by placing a firm order for 50 Boeing 737-8 jets, significantly boosting its existing portfolio. This latest acquisition expands the company's 737 MAX collection to a total of 215 aircraft, which includes both 737-8s and 737-9s. With this order, BOC Aviation will have a...
Continue Reading
Bluebird Bio's Stock Hits Record Low: A Closer Look Bluebird bio Inc has recently experienced a dramatic downturn in its stock performance, plummeting to a noteworthy 52-week low of $0.46. This decline represents a staggering reduction of approximately 84.68% over the course of a year, revealing the mounting difficulties the biotech company is grappling with. Investor...
Continue Reading